Gemtuzumab
Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.
Year introduced: 2020 (2000)
PubMed search builder options
Subheadings:
Tree Number(s): D09.408.051.247.500, D12.776.124.486.485.114.224.060.790, D12.776.124.790.651.114.224.060.790, D12.776.377.715.548.114.224.200.790
MeSH Unique ID: D000079982
Registry Number: 93NS566KF7
Entry Terms:
- CMA 676
- CMA-676
- CMA676
- Mylotarg
- Gemtuzumab Ozogamicin
- Gemtuzumab-Ozogamicin
Pharmacologic Action: